Pure Bioscience (PURE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
(Values in U.S. thousands)
| 07-2025 | 07-2024 | 07-2023 | 07-2022 | 07-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 409 | 424 | 1,170 | 3,466 | 2,465 |
| Receivables | 474 | 298 | 285 | 201 | 368 |
| Inventories | 141 | 56 | 88 | 179 | 332 |
| TOTAL | $1,047 | $805 | $1,604 | $3,864 | $3,197 |
| Non-Current Assets | |||||
| PPE Net | 11 | 13 | 221 | 620 | 740 |
| Intangibles | 0 | 0 | 0 | 0 | 366 |
| TOTAL | $11 | $13 | $221 | $620 | $1,106 |
| Total Assets | $1,058 | $818 | $1,825 | $4,484 | $4,303 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 239 |
| Accounts payable and accrued liabilities | 784 | 601 | 422 | 488 | 593 |
| Accrued Expenses | 154 | 132 | 110 | 87 | 138 |
| TOTAL | $938 | $733 | $532 | $575 | $970 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,236 | 2,949 | 1,021 | N/A | N/A |
| TOTAL | $5,236 | $2,949 | $1,021 | $N/A | $N/A |
| Total Liabilities | $6,174 | $3,682 | $1,553 | $575 | $970 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 111,887 | 111,857 | 111,857 | 111,357 | 87,223 |
| Common Shares | 1,119 | 1,119 | 1,119 | 1,114 | 873 |
| Retained earnings | -138,994 | -136,595 | -133,245 | -129,284 | -125,793 |
| TOTAL | $-5,116 | $-2,864 | $272 | $3,909 | $3,333 |
| Total Liabilities And Equity | $1,058 | $818 | $1,825 | $4,484 | $4,303 |